Security
Shuttle Pharmaceuticals Holdings, Inc. Common Stock · SHPH
SHPHNASDAQCommon stockCurrentCIK 1757499Updated Oct 23, 2026
Name history
Shuttle Pharmaceuticals Holdings, Inc. · through Oct 22, 2026
SHPH price & chart
Loading TradingView…
NASDAQ:SHPH on TradingView ↗About the company
Shuttle Pharma is a clinical stage pharmaceutical company leveraging our proprietary technology to develop novel therapies designed to cure cancers. Our goal is to extend the benefits of cancer treatments with surgery, radiation therapy, chemotherapy and immunotherapy. Radiation therapy (“radiation therapy” or “RT”) is one of the most effective modalities for treating cancers. We are developing a pipeline of products designed to address the limitations of the current cancer therapies as well as to extend to the new applications of RT. We believe that our product candidates will enable us to deliver cancer treatments that are safer, more reliable and at a greater scale than that of the current standard of care.
In the news
Seeking Alpha
Shuttle Pharmaceuticals gets Nasdaq notice after missing 10-Q filing deadline ↗
Short Interest Alert: Most and least shorted sub-$2B healthcare stocks in July 2026 ↗
Shuttle Pharmaceuticals announces $3.5 million public offering ↗
SEC disclosures
Shuttle Pharmaceuticals Holdings, Inc. files 8-K/A ↗
Recent filings
Changes in Registrant's Certifying Accountant
Items 4.01, 9.01
10-Q filing
Financial Statements and Exhibits
Items 9.01
Unregistered Sales of Equity Securities
Items 3.02, 9.01
Submission of Matters to a Vote of Security Holders
Items 5.07, 9.01
Show 5 more recent filings
DEFA14A filing
Other Events
Items 8.01, 9.01
Entry into a Material Definitive Agreement
Items 1.01, 9.01
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing · Regulation FD Disclosure
Items 3.01, 7.01, 9.01
NT 10-Q filing
Financials
FY 2025 · USDSource
Source
Source
Source
Source
balance sheet · annual statements
| Line item | Q3 2025 | Q3 2024 | Q2 2026 | Q2 2025 | Q2 2024 | Q1 2026 | Q1 2025 | Q1 2024 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||||||
| AssetsUSD | 3,542,927Source | 673,568Source | 22,811,038Source | 5,504,429Source | 2,812,998Source | 11,809,327Source | 5,310,190Source | 4,753,921Source | 10,475,977Source | 2,506,290Source | 5,951,736Source | 8,653,545Source |
| Property, Plant and Equipment, NetUSD | 18,327Source | 21,160Source | 15,191Source | 19,335Source | 21,953Source | 16,311Source | 18,356Source | 22,915Source | 17,319Source | 19,364Source | 24,827Source | 12,592Source |
| Intangible Assets, Net (Excluding Goodwill)USD | — | — | 8,648,579Source | — | — | 9,244,910Source | — | — | 9,841,242Source | — | — | — |
| Current assets: | ||||||||||||
| Cash and Cash Equivalents, at Carrying ValueUSD | 2,094,643Source | 156,656Source | 90,238Source | 4,817,672Source | 695,594Source | 1,089,946Source | 4,512,607Source | 1,398,628Source | 334,005Source | 1,920,144Source | 2,576,416Source | 8,417,203Source |
| Assets, CurrentUSD | 3,265,913Source | 361,351Source | 396,353Source | 5,191,917Source | 2,485,333Source | 2,462,953Source | 4,959,397Source | 4,411,019Source | 502,911Source | 2,210,917Source | 5,593,005Source | 8,578,351Source |
| Prepaid Expense and Other Assets, CurrentUSD | 1,171,270Source | — | 306,115Source | — | — | 1,373,007Source | — | — | 168,906Source | — | — | — |
| Operating Lease, Right-of-Use AssetUSD | 228,382Source | 291,057Source | 67,441Source | 244,690Source | 305,712Source | 85,153Source | 260,557Source | 319,987Source | 102,383Source | 276,009Source | 333,904Source | 56,122Source |
| LIABILITIES AND EQUITY | ||||||||||||
| LiabilitiesUSD | 2,148,766Source | 1,988,945Source | 3,628,859Source | 1,898,910Source | 2,011,564Source | 8,463,084Source | 2,024,925Source | 1,992,434Source | 8,221,531Source | 1,797,138Source | 1,895,965Source | 975,676Source |
| Stockholders’ equity: | ||||||||||||
| Common Stock, Value, IssuedUSD | 13Source | 29Source | 9Source | 11Source | 21Source | 57Source | 63Source | 21Source | 20Source | 41Source | 20Source | 136Source |
| Additional Paid in CapitalUSD | 45,079,023Source | 31,664,226Source | 70,779,950Source | 44,943,081Source | 29,996,963Source | 51,798,427Source | 40,916,310Source | 29,925,801Source | 48,554,196Source | 35,287,212Source | 29,489,055Source | — |
| Retained Earnings (Accumulated Deficit)USD | -43,684,875Source | -32,979,632Source | -51,597,780Source | -41,337,573Source | -29,195,550Source | -48,452,241Source | -37,631,108Source | -27,164,335Source | -46,299,770Source | -34,578,101Source | -25,433,304Source | -8,894,889Source |
| Stockholders' Equity Attributable to ParentUSD | 1,394,161Source | -1,315,377Source | 19,182,179Source | 3,605,519Source | 801,454Source | 3,346,243Source | 3,285,265Source | 2,761,487Source | 2,254,446Source | 709,152Source | 4,055,771Source | 7,677,869Source |
| Additional Paid in Capital, Common StockUSD | — | — | — | — | — | — | — | — | — | — | — | 16,572,622Source |
| Liabilities and EquityUSD | 3,542,927Source | 673,568Source | 22,811,038Source | 5,504,429Source | 2,812,998Source | 11,809,327Source | 5,310,190Source | 4,753,921Source | 10,475,977Source | 2,506,290Source | 5,951,736Source | 8,653,545Source |
| Current liabilities: | ||||||||||||
| Liabilities, CurrentUSD | 1,964,910Source | 1,659,233Source | 3,480,761Source | 1,692,786Source | 1,384,620Source | 8,305,610Source | 1,782,177Source | 1,489,217Source | 7,966,891Source | 1,533,769Source | 1,042,237Source | 975,676Source |
| Operating Lease, Liability, CurrentUSD | 74,497Source | 58,652Source | 82,811Source | 71,869Source | 62,092Source | 79,962Source | 63,226Source | 54,552Source | 77,194Source | 60,909Source | 52,479Source | 62,823Source |
| Operating Lease, Liability, NoncurrentUSD | 175,318Source | 255,605Source | 112,347Source | 195,159Source | 267,025Source | 134,051Source | 220,110Source | 288,602Source | 154,953Source | 238,088Source | 304,127Source | — |
cash flow · annual statements
| Line item | Q4 2025 | Q4 2024 | Q3 2025 | Q3 2024 | Q2 2026 | Q2 2025 | Q1 2026 | Q1 2025 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash flows from operating activities: | ||||||||||||
| Net Income (Loss), Including Portion Attributable to Noncontrolling InterestUSD | — | — | — | — | — | — | — | -3,000,000Source | — | -9,539,875Source | — | — |
| Adjustments to reconcile net income to net cash provided by operating activities: | ||||||||||||
| Depreciation and amortization | — | — | — | — | — | — | —Source | —Source | —Source | — | — | — |
| Share-based Payment Arrangement, Noncash ExpenseUSD | — | — | — | — | — | — | 35,018Source | 537,046Source | 932,967Source | 259,744Source | 181,960Source | 403,956Source |
| Net Cash Provided by (Used in) Operating ActivitiesUSD | — | — | — | — | — | — | -2,417,309Source | -2,526,924Source | -9,481,645Source | -7,327,230Source | -5,581,147Source | -2,710,454Source |
| Cash flows from investing activities: | ||||||||||||
| Net Cash Provided by (Used in) Investing ActivitiesUSD | — | — | — | — | — | — | -36,000Source | — | -3,056,722Source | 2,915,765Source | -2,829,723Source | — |
| Payments to Acquire Property, Plant, and EquipmentUSD | — | — | — | — | — | — | — | — | — | — | 19,046Source | — |
| Cash flows from financing activities: | ||||||||||||
| Net Cash Provided by (Used in) Financing ActivitiesUSD | — | — | — | — | — | — | 3,209,250Source | 5,119,387Source | 10,952,228Source | 3,755,193Source | 2,570,083Source | 10,622,908Source |
| Repayments of Long-term DebtUSD | — | — | — | — | — | — | — | — | — | 59,730Source | — | — |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate EffectUSD | — | — | — | — | — | — | 755,941Source | 2,592,463Source | -1,586,139Source | -656,272Source | -5,840,787Source | 7,912,454Source |
| Supplemental disclosure of cash flow information: | ||||||||||||
| Interest Paid, Excluding Capitalized Interest, Operating ActivitiesUSD | — | — | — | — | — | — | — | 36,153Source | 125,296Source | 86,589Source | 164,807Source | 39,201Source |
| Additional Financial Items | ||||||||||||
| Share-based Payment Arrangement, ExpenseUSD | — | — | 134,318Source | 45,275Source | -7,511Source | 46,853Source | — | 500,000Source | 932,967Source | 259,744Source | — | — |
| Amortization of Debt Issuance CostsUSD | — | — | — | — | — | 50,000Source | — | 50,000Source | — | — | 1,523,768Source | — |
| Amortization of Debt Issuance Costs and DiscountsUSD | — | — | — | — | — | — | — | — | — | — | — | 408,979Source |
| Amortization of Intangible AssetsUSD | — | — | — | — | — | — | 632,332Source | — | 288,062Source | — | — | — |
| DepreciationUSD | — | — | — | — | — | — | — | 1,008Source | — | 5,463Source | 6,811Source | 5,972Source |
| Derivative, Gain (Loss) on Derivative, NetUSD | — | — | 2,427Source | 286,316Source | 48,785Source | 11,673Source | 76,264Source | 2,643Source | -74,406Source | 555,789Source | 2,216,488Source | — |
| Gain (Loss) on Sale of InvestmentsUSD | — | — | — | 56,398Source | — | — | — | — | — | 28,550Source | 4,970Source | — |
| Gain (Loss) on Extinguishment of DebtUSD | — | — | — | — | 755,121Source | — | — | — | 342,650Source | — | — | 328,687Source |
| General and Administrative ExpenseUSD | — | — | 886,055Source | 328,995Source | 1,984,907Source | 2,346,323Source | 1,160,556Source | 596,886Source | 5,672,794Source | 1,392,709Source | 1,046,854Source | 198,978Source |
| Investment Income, InterestUSD | — | — | 486Source | 2,524Source | 90Source | 81Source | 209Source | — | 1,090Source | 38,138Source | 79,117Source | — |
| Marketable Securities, Gain (Loss), Excluding Other-than-temporary Impairment LossUSD | — | — | — | — | — | — | — | — | — | — | 71,568Source | — |
| Marketable Securities, Realized Gain (Loss), Excluding Other-than-temporary Impairment LossUSD | — | — | — | — | — | — | — | — | — | — | 4,970Source | — |
| Marketable Securities, Unrealized Gain (Loss)USD | — | — | — | -42,898Source | — | — | — | — | — | — | 71,568Source | — |
| Net Income (Loss) Attributable to ParentUSD | — | — | -2,347,302Source | -3,784,082Source | -3,145,539Source | -3,706,465Source | -2,152,471Source | -3,053,007Source | -11,721,669Source | -9,144,797Source | -6,592,723Source | -3,028,448Source |
| Net Income (Loss) Available to Common Stockholders, BasicUSD | — | — | — | — | — | — | — | — | — | — | -6,592,723Source | -3,099,457Source |
| Nonoperating Income (Expense)USD | — | — | -80,360Source | -732,521Source | 803,996Source | 203,941Source | 64,351Source | -101,766Source | 195,155Source | -1,448,627Source | -700,341Source | -474,170Source |
| Operating ExpensesUSD | — | — | 2,266,942Source | 3,051,561Source | 3,949,535Source | 3,910,406Source | 2,216,822Source | 2,951,241Source | 11,916,824Source | 7,696,170Source | 5,892,382Source | 2,554,278Source |
| Operating Lease, ExpenseUSD | — | — | — | — | — | — | — | — | — | — | — | 70,175Source |
| Payments of Financing CostsUSD | — | — | — | — | — | — | — | 50,001Source | 74,152Source | — | 345,000Source | — |
| Proceeds from Issuance of Common StockUSD | — | — | — | — | — | — | 3,225,000Source | 5,409,673Source | — | 3,992,675Source | — | 10,022,193Source |
income statement · annual statements
| Line item | Q4 2025 | Q4 2024 | Q3 2025 | Q3 2024 | Q2 2026 | Q2 2025 | Q1 2026 | Q1 2025 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Income (Loss)USD | — | — | -2,266,942Source | -3,051,561Source | -3,949,535Source | -3,910,406Source | -2,216,822Source | -2,951,241Source | -11,916,824Source | -7,696,170Source | -5,892,382Source | -2,554,278Source |
| Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling InterestUSD | — | — | — | — | — | — | — | — | — | — | -6,592,723Source | -3,028,448Source |
| Net Income (Loss) Attributable to ParentUSD | — | — | -2,347,302Source | -3,784,082Source | -3,145,539Source | -3,706,465Source | -2,152,471Source | -3,053,007Source | -11,721,669Source | -9,144,797Source | -6,592,723Source | -3,028,448Source |
| Earnings Per Share, BasicUSD per share | — | — | -1.05Source | -39.83Source | -3.1Source | -32.91Source | -0.43Source | -7.6Source | -7.16Source | -3.19Source | -3.53Source | -0.29Source |
| Earnings Per Share, DilutedUSD per share | — | — | -1.05Source | -39.83Source | -3.1Source | -32.91Source | -0.43Source | -7.6Source | -7.16Source | -3.3Source | -3.53Source | — |
| Weighted Average Number of Shares Outstanding, Basicshares | — | — | 2,233,650Source | 95,004Source | 1,015,181Source | 112,611Source | 5,031,569Source | 401,957Source | 1,637,926Source | 2,870,120Source | 1,866,275Source | 10,351,046Source |
| Weighted Average Number of Shares Outstanding, Dilutedshares | — | — | 2,233,650Source | 95,004Source | 1,015,181Source | 112,611Source | 5,031,569Source | 401,957Source | 1,637,926Source | 2,887,268Source | 1,866,275Source | — |
| Additional Financial Items | ||||||||||||
| Amortization of Intangible AssetsUSD | — | — | — | — | — | — | 632,332Source | — | 288,062Source | — | — | — |
| Costs and ExpensesUSD | — | — | — | — | — | — | — | — | 2,400,000Source | 2,100,000Source | — | — |
| Debt Securities, Gain (Loss)USD | — | — | — | 762,186Source | — | — | — | — | — | 800,000Source | — | -12,625Source |
| Depreciation, Depletion and Amortization, NonproductionUSD | — | — | — | — | — | — | 633,340Source | 1,008Source | 290,107Source | — | — | — |
| General and Administrative ExpenseUSD | — | — | 886,055Source | 328,995Source | 1,984,907Source | 2,346,323Source | 1,160,556Source | 596,886Source | 5,672,794Source | 1,392,709Source | 1,046,854Source | 198,978Source |
| Income (Loss) from Continuing Operations before Income Taxes, DomesticUSD | — | — | — | — | — | — | — | — | 11,431,788Source | — | — | — |
| Interest Expense, DebtUSD | — | — | — | — | — | — | — | — | — | — | 2,123,049Source | 917,879Source |
| Interest Income (Expense), NetUSD | — | — | — | — | — | — | — | — | — | 100,000Source | 52,855Source | — |
| Investment Income, InterestUSD | — | — | 486Source | 2,524Source | 90Source | 81Source | 209Source | — | 1,090Source | 38,138Source | 79,117Source | — |
| Marketable Securities, Realized Gain (Loss), Excluding Other-than-temporary Impairment LossUSD | — | — | — | — | — | — | — | — | — | — | 4,970Source | — |
| Net Income (Loss) Available to Common Stockholders, BasicUSD | — | — | — | — | — | — | — | — | — | — | -6,592,723Source | -3,099,457Source |
| Nonoperating Income (Expense)USD | — | — | -80,360Source | -732,521Source | 803,996Source | 203,941Source | 64,351Source | -101,766Source | 195,155Source | -1,448,627Source | -700,341Source | -474,170Source |
| Operating ExpensesUSD | — | — | 2,266,942Source | 3,051,561Source | 3,949,535Source | 3,910,406Source | 2,216,822Source | 2,951,241Source | 11,916,824Source | 7,696,170Source | 5,892,382Source | 2,554,278Source |
| Operating Lease, ExpenseUSD | — | — | — | — | — | — | — | — | — | — | — | 70,175Source |
| Preferred Stock Dividends, Income Statement ImpactUSD | — | — | — | — | — | — | — | — | — | — | — | 71,009Source |
| Research and Development ExpenseUSD | — | — | 943,478Source | 1,400,564Source | 55,661Source | 1,025,547Source | 267,240Source | 1,573,928Source | 4,054,831Source | 3,618,796Source | 3,517,093Source | 1,488,530Source |
| Other Expenses | — | — | — | — | — | —Source | — | —Source | — | — | — | — |
Offerings
Registration 333-293363
Registration 333-291628
Registration 333-289231
Registration 333-284889
Underwriters: WestPark Capital, Inc.
Registration 333-284286
Filing attachments
ex99-1.htm · 8-K · 2026-08-28
EX-99.1 2 ex99-1.htm EX-99.1 Exhibit 99.1 Shuttle Pharmaceuticals Holdings, Inc. Announces Receipt of NASDAQ Noncompliance Letter Gaithersburg, Maryland, August 28, 2026 - Shuttle Pharmaceuticals Holdings, Inc. (NASDAQ: SHPH) (the “Company” or “Shuttle”), today announced that the Company is not in compliance with the periodic filing requirements for continued listing set forth in Nasdaq Listing Rule 5250(c)(1) as a result of its failure to file its Quarterly Report on Form 10-Q for the fis…
Read attachment ↗ex99-1.htm · 8-K · 2026-07-01
EX-99.1 2 ex99-1.htm EX-99.1 Exhibit 99.1 United Dogecoin Advances Data Centre and Power Infrastructure Strategy to Support DOGE Mining and AI Hosting United Dogecoin shares insights on its digital infrastructure strategy, aimed at expanding revenue opportunities and supporting long-term shareholder value creation. Gaithersburg, Maryland - (June 25, 2026) - United Dogecoin Inc. (“United Dogecoin” or the “Company”), a Dogecoin mining and digital infrastructure company driven by industry ex…
Read attachment ↗ex99-2.htm · 8-K · 2026-07-01
EX-99.2 3 ex99-2.htm EX-99.2 Exhibit 99.2 United Dogecoin Purchases Dogecoin Miners and Secures Renewable Energy Data Centre Site United Dogecoin looks to have its miners operational within approximately 60 days, leveraging low-cost, renewable energy, on its path to being the market’s largest Dogecoin miner by hashrate Gaithersburg, Maryland - June 26, 2026 - United Dogecoin Inc. (“United Dogecoin” or the “Company”), a Dogecoin mining company driven by industry experts recently acquired b…
Read attachment ↗ex99-1.htm · 8-K · 2026-05-01
EX-99.1 6 ex99-1.htm EX-99.1 Exhibit 99.1 Shuttle Merges with United Dogecoin to Become the World’s Largest Public Dogecoin Miner The combination and related financing is expected to result in the largest publicly listed Dogecoin mining company based on percentage of the global hashrate Gaithersburg, Maryland, April 30, 2026 - Shuttle Pharmaceutical Holdings, Inc. (NASDAQ: SHPH) (“Shuttle”) has entered into a definitive merger agreement to acquire United Dogecoin Inc. (“United Dogecoin” o…
Read attachment ↗ex4-1.htm · 8-K · 2026-03-10
EX-4.1 2 ex4-1.htm EX-4.1 Exhibit 4.1 SHUTTLE PHARMACEUTICALS HOLDINGS, INC. PRE-FUNDED WARRANT Warrant Initial Shares: [ ] Exercise Date: [_______], 2026 Issue Date: [_______], 2026 THIS PRE-FUNDED WARRANT (the “ Warrant ”) certifies that, for value received, [_______] or its assigns (the “ Holder ”) is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on or af…
Read attachment ↗